BioCardia (BCDA) Other Accumulated Expenses (2022 - 2024)

BioCardia (BCDA) has reported Other Accumulated Expenses for 3 consecutive years, with $42000.0 the latest figure, recorded in Q2 2024.

• On a quarterly basis, Other Accumulated Expenses rose 121.05% year-over-year to $42000.0 in Q2 2024; TTM through Jun 2024 was $42000.0, a 121.05% increase from a year earlier, with the FY2023 full-year figure at $79000.0, up 338.89% from the prior year.
• Other Accumulated Expenses was $42000.0 for Q2 2024 at BioCardia, roughly flat from $42000.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $79000.0 in Q4 2023 and troughed at $18000.0 in Q4 2022.
• A 3-year average of $41285.7 and a median of $42000.0 in 2024 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses jumped 338.89% in 2023 and grew 27.27% in 2024, its largest moves.
• Over 3 years, Other Accumulated Expenses stood at $18000.0 in 2022, then surged by 338.89% to $79000.0 in 2023, then sank by 46.84% to $42000.0 in 2024.
• The last three Other Accumulated Expenses figures came in at $42000.0 (Q2 2024), $42000.0 (Q1 2024), and $79000.0 (Q4 2023), per Business Quant data.